S. Pini, N. Baldini Rossi, D. Bravi, P. Donda - Vol. 6, Marzo 2000, num.1
Testo Immagini Bibliografia Summary Riassunto Indice
La fluoxetina nel trattamento del disturbo
distimico
Fluoxetine in the treatment of dysthymic disorder
Akiskal HS.
Dysthymic disorders psychopathology of proposed chronic depressive subtypes.
Am J Psychiatry l983;140:11-20.
Akiskal HS.
Towards a definition of dysthymia; boundaries with personality and mood disorders.
In: Burton SW, Akiskal US, eds. Dysthymic Disorder, Gaskell, London,
pp. 1-12.
Akiskal HS.
La dysthymie et son traitment.
Encéphale 1993;19:375-378.
Alby JM, Cabane J, Ferreri M, Bougerol T.
Efficacy and Acceptability of Tianeptine in Major Depressive Disorder and
in Dysthymia (DSM-III-R) with somatic complaints: double-blind study versus
Fluoxetine.
European Neuropsychopharmacology 1993;3:333.
American Psychiatric Association.
Diagnostic and Statistical Manual of Mental Disorders.
Washington DC: Third Edition (1980).
American Psychiatric Association.
Diagnostic and Statistical Manual of Mental Disorders.
Washington, DC: Third Edition - Revised (1987).
American Psychistric Association.
Diagnostic and Statistical Manual of Mental Disorders.
Washington DC: Fourth Edition (l994).
Birmaher B.
Should we use antidepressant medications for children and adolesecuts with
depressive disorders?
Psychopharmacol Bull 1998;34:35-39.
Dunner DL, Schmaling KB, Hendrickson H, Becker J, Lehman A, Bea C.
Cognitive therapy versus fluoxetine in the treatment of dysthymic disorder.
Depression 1996;4:34-41.
Dunner DL.
Treatment of dysthymic disorder.
Depression and Anxiety l998;(Suppl. 1):54-58.
Hellerstein DJ, Yanowitch P, Rosenthal J, Samstag LW, Maurer M, Kasch K, Burrows
L, Poster M, Cantillon M, Winston A.
A Randomized Double Blind Study of Fluoxetinee Versus Placebo in the Treatment
of Dysthymia.
Am J Psychiatry 1993;150:1169-1175.
Hellerstein DJ, Samstag LW, Cantillon M, Maurer M, Rosenthal J, Yanowitch
P, Winston A.
Follow-up assessment of medication-treated dysthymia.
Prog Neuropsychopharmacol Biol Psychiatry 1996;20:427-442.
Kocsis JH.
Geriatric dysthymia.
J Clin Psychiatr 1998;59(Suppl.10):13-15.
Menna-Perper M, Swartzburg M, Mueller PS, Rochford J, Manowitz P.
Free tryptophan response to intravenous insulin in depressed patients.
Biol Psychiatry 1983;18:771-780.
McKeith IG, Marshall EF, Ferrier IN e Coll.
5-HT receptor binding in post-mortem brain from patients with affective disorder.
J Affect Dis 1987;13:67-74.
Nobler MS, Devanand DP, Kim MK, Fitzsimons LM, Singer TM, Turret N, Sackeim
HA, Roose SP.
Fluoxetine treatment of dysthymia in the elderly.
J Clin Psychiatry l996 Jun;57:254-256.
Pringuey D, Bovier P, Chiaroni P, e Coll.
Membrane transport of L-tyrosine and L-tryptophan in red blood cells: Preliminary
results in a group of 66 depressed patients.
Acta Psychiatr Bel 1986;86:131-140.
Ravindran AV, Bialik RJ, Lapierre VD.
Primary early onset dysthymia, biochemical correlates of the therapeutic response
to fluoxetine: I. Platelet monoamine oxidase and the dexamethasone suppression
test.
J Affect Disord l994 Jun;31:119-123.
Ravindran AV, Bialik RJ, Brown GM, Lapierre YD.
Primary early onser dysthymia, biochemical correlates of the therapeutic response
to fluoxetine: II. Urinary metabolites of serotonin, norepinephrine, epinephrine
and melatonin.
J Affect Disord 1994;31:111-117.
Ravindran AV, Bialik RJ, Lapierre YD.
Therapeutic efficacy of Specific Serotonin Reuptake Inhibitors (SSRI) in Dysthymia.
Canadian Journal of Psychiatry 1994;39:21-26.
Revicki DA, Wood M.
Patient-assigned health state utilities for depression-related outcomes: differences
by depression severity and antidepressant medications.
J Affect Disord 1998 Feb;48:25-36.
Roy A, Pickar D, Linnoila M, Doran AR, Ninan P, Paul SM.
Cerebrospinal fluid monoamine and monoamine metabolite concentrations in melancholia.
Psychiatry Res 1985;15:281-292.
Roy A, Everett D, Pickar D, Doran AR, Paul SM.
Platelet-tritiated imipramine binding and serotonin uptake in depressed patients
and controls.
Arch Gen Psychiatry 1987;44:320-327.
Rosenthal J, Hemlock C, Hellerstein DJ, Yanowitch P, Kasch K, Schupak C, Samstag
LW, Winston A.
A preliminary study of Serotoninergic Antidepressants in Treatment of Dysthymia.
Progress in Neuropsychopharmacology and Biological Psychiatry 1992;16:933-941.
Sarikaya A, Karasin E, Cermic TF, Abay E, Berkarda S.
Evaluation of lysthymic disorder with technetium-99m hexamethylpropylene amine
oxime brain single-photon emission tomography.
Eur J Nucl Med 1999;26:260-264.
Shelton RC, Davidson J, Yonkers KA, Koran L, Thase ME, Pearlstein T, Halbreich
U.
The undertreatment of dysthymia.
J Clin Psychiatry 1997;58:59-65.
Smeraldi E.
Amisulpride versus fluoxetine in patients with dysthymia or major depression
in partial remission: a double-blind, comparative study.
J Affect Disord 1998;48:47-56.
Tripodianakis J, Markianos M, Sarantidis D, Spyropoulou G, Taktikou V, Bistolaki
E.
Platelet MAO activity in patients with dysthymic disorder.
Psychiatry Res 1998;78:173-178.
Vanelle JM, Arrar-Levy D, Poirer MF, Bouhassira M, Blin P, Olie JP.
Controlled efficacy study of fluoxetine in dysthymia.
Br J Psychiatry 1997;170:345-350.
World Health Organization.
International classification of Diseases.
Geneva: Tenth Edition 1992.